Clinical Research Directory

Inclusion Criteria: * Individual who is 18 years or older * Individual who has signed the informed consent * Individual with: --A first-degree relative who has (or had) pancreatic ductal adenocarcinoma (PDAC) OR a second-degree relative who has (or had) PDAC and has a known germline mutation in APC, ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, STK11, or TP53 * The germline mutation and history of PDAC must be on the maternal side or paternal side of the individual's family * Individual with a valid United States mailing address * Individual with access to a healthcare provider and is willing to share genetic test results with that provider/the study team Exclusion Criteria: * Individual with a known cancer susceptibility gene * Individual who has received genetic counseling for cancer risk within the last 3 years * Individual who has received a bone marrow transplant, who has had a blood transfusion within the last 7 days, or who has an active hematologic malignancy (i.e. leukemia or lymphoma) * Individual who is unable to sign the informed consent because of mental incompetency or psychiatric illness * Individual who is unwilling to complete baseline and follow-up questionnaires * Individual who has a life expectancy of less than 1 year * Individual with only APC I1307K mutation within their family * Individual with only PMS2 exons 12-15 deletion mutation within their family